Relationship between chronic kidney disease and metabolic syndrome: current perspectives

References

• Kylin E Studies of the hypertension-hyperglycemia-hyperuricemia syndrome Zentralbl Inn Med 1923 44 105 127 German
   Google Scholar
• Herman JB Medalie JH Goldbourt U Diabetes, prediabetes and uricaemia Diabetologia 1976 12 1 47 52 1254115
   PubMed Web of Science ®Google Scholar
• Reaven GM Banting Lecture 1988. Role of insulin resistance in human disease Diabetes 1988 37 12 1595 1607 3056758
   PubMed Web of Science ®Google Scholar
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 2002 106 25 3143 3421 12485966
   PubMed Web of Science ®Google Scholar
• Obunai K Jani S Dangas GD Cardiovascular morbidity and mortality of the metabolic syndrome Med Clin North Am 2007 91 6 1169 1184 x 17964915
   PubMed Web of Science ®Google Scholar
• Caterson ID Hubbard V Bray GA American Heart Association Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity Circulation 2004 110 18 e476 e483 15520332
   PubMed Web of Science ®Google Scholar
• Ford ES Giles WH Dietz WH Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey JAMA 2002 287 3 356 359 11790215
   PubMed Web of Science ®Google Scholar
• Athyros VG Ganotakis ES Tziomalos K Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population Curr Med Res Opin 2010 26 3 713 719 20078335
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Gobal Outcomes (KDIGO) CKD Work Group KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease Kidney Int Supp 2013 3 1 1 150
   Web of Science ®Google Scholar
• Go AS Chertow GM Fan D McCulloch CE Hsu CY Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 2004 351 13 1296 1305 15385656
   PubMed Web of Science ®Google Scholar
• Tonelli M Wiebe N Culleton B Chronic kidney disease and mortality risk: a systematic review J Am Soc Nephrol 2006 17 7 2034 2047 16738019
   PubMed Web of Science ®Google Scholar
• Mottillo S Filion KB Genest J The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis J Am Coll Cardiol 2010 56 14 1113 1132 20863953
   PubMed Web of Science ®Google Scholar
• Li W Ma D Liu M Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies Cerebrovasc Dis 2008 25 6 539 547 18480607
   PubMed Web of Science ®Google Scholar
• Wu SH Hui WS Liu Z Ho SC Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies Eur J Epidemiol 2010 25 6 375 384 20425137
   PubMed Web of Science ®Google Scholar
• Agrawal S Shlipak MG Kramer H Jain A Herrington DM The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: multiethnic study of atherosclerosis Cardiol Res Pract 2012 2012 806102 21860804
   PubMedGoogle Scholar
• Kunimura A Amano T Uetani T Prognostic impact of concurrence of metabolic syndrome and chronic kidney disease in patients undergoing coronary intervention: involvement of coronary plaque composition J Cardiol 2013 61 3 189 195 23182943
   PubMed Web of Science ®Google Scholar
• Kim CS Choi JS Bae EH Korea Acute Myocardial Infarction Registry Investigators Association of metabolic syndrome and renal insufficiency with clinical outcome in acute myocardial infarction Metabolism 2013 62 5 669 676 23218489
   PubMed Web of Science ®Google Scholar
• Chan DT Watts GF Irish AB Ooi EM Dogra GK Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease Am J Hypertens 2013 26 9 1155 1161 23736110
   PubMed Web of Science ®Google Scholar
• Xu H Huang X Arnlöv J Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4 Clin J Am Soc Nephrol 2014 9 4 690 697 24436478
   PubMed Web of Science ®Google Scholar
• Johnson DW Armstrong K Campbell SB Metabolic syndrome in severe chronic kidney disease: prevalence, predictors, prognostic significance and effects of risk factor modification Nephrology (Carlton) 2007 12 4 391 398 17635756
   PubMed Web of Science ®Google Scholar
• Chen J Muntner P Hamm LL The metabolic syndrome and chronic kidney disease in US adults Ann Intern Med 2004 140 3 167 174 14757614
   PubMed Web of Science ®Google Scholar
• Palaniappan L Carnethon M Fortmann SP Association between microalbuminuria and the metabolic syndrome: NHANES III Am J Hypertens 2003 16 11 Pt 1 952 958 14573334
   PubMed Web of Science ®Google Scholar
• Kurella M Lo JC Chertow GM Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults J Am Soc Nephrol 2005 16 7 2134 2140 15901764
   PubMed Web of Science ®Google Scholar
• Cuspidi C Meani S Fusi V Metabolic syndrome and target organ damage in untreated essential hypertensives J Hypertens 2004 22 10 1991 1998 15361772
   PubMed Web of Science ®Google Scholar
• Mulè G Nardi E Cottone S Influence of metabolic syndrome on hypertension-related target organ damage J Intern Med 2005 257 6 503 513 15910554
   PubMed Web of Science ®Google Scholar
• Chen J Gu D Chen CS Association between the metabolic syndrome and chronic kidney disease in Chinese adults Nephrol Dial Transplant 2007 22 4 1100 1106 17272313
   PubMed Web of Science ®Google Scholar
• Lucove J Vupputuri S Heiss G North K Russell M Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study Am J Kidney Dis 2008 51 1 21 28 18155529
   PubMed Web of Science ®Google Scholar
• Sun F Tao Q Zhan S Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort Nephrology (Carlton) 2010 15 1 84 92 20377775
   PubMed Web of Science ®Google Scholar
• Tanaka H Shiohira Y Uezu Y Higa A Iseki K Metabolic syndrome and chronic kidney disease in Okinawa, Japan Kidney Int 2006 69 2 369 374 16408128
   PubMed Web of Science ®Google Scholar
• Chang IH Han JH Myung SC Association between metabolic syndrome and chronic kidney disease in the Korean population Nephrology (Carlton) 2009 14 3 321 326 19444966
   PubMed Web of Science ®Google Scholar
• Surendar J Indulekha K Aravindhan V Ganesan A Mohan V Association of cystatin-C with metabolic syndrome in normal glucose-tolerant subjects (CURES-97) Diabetes Technol Ther 2010 12 11 907 912 20879967
   PubMed Web of Science ®Google Scholar
• Yang T Chu CH Hsu CH Impact of metabolic syndrome on the incidence of chronic kidney disease: a Chinese cohort study Nephrology (Carlton) 2012 17 6 532 538 22487238
   PubMed Web of Science ®Google Scholar
• Ninomiya T Kiyohara Y Kubo M Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study Am J Kidney Dis 2006 48 3 383 391 16931211
   PubMed Web of Science ®Google Scholar
• Ryu S Chang Y Woo HY Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes Am J Kidney Dis 2009 53 1 59 69 18838200
   PubMed Web of Science ®Google Scholar
• Thomas G Sehgal AR Kashyap SR Srinivas TR Kirwan JP Navaneethan SD Metabolic syndrome and kidney disease: a systematic review and meta-analysis Clin J Am Soc Nephrol 2011 6 10 2364 2373 21852664
   PubMed Web of Science ®Google Scholar
• Rashidi A Ghanbarian A Azizi F Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population Clin J Am Soc Nephrol 2007 2 5 976 983 17702729
   PubMed Web of Science ®Google Scholar
• Alexander MP Patel TV Farag YM Florez A Rennke HG Singh AK Kidney pathological changes in metabolic syndrome: a cross-sectional study Am J Kidney Dis 2009 53 5 751 759 19339092
   PubMed Web of Science ®Google Scholar
• Kohler KA McClellan WM Ziemer DC Kleinbaum DG Boring JR Risk factors for microalbuminuria in black Americans with newly diagnosed type 2 diabetes Am J Kidney Dis 2000 36 5 903 913 11054346
   PubMed Web of Science ®Google Scholar
• Hoehner CM Greenlund KJ Rith-Najarian S Casper ML McClellan WM Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project J Am Soc Nephrol 2002 13 6 1626 1634 12039992
   PubMed Web of Science ®Google Scholar
• Niskanen LK Penttilã I Parviainen M Uusitupa MI Evolution, risk factors, and prognostic implications of albuminuria in NIDDM Diabetes Care 1996 19 5 486 493 8732714
   PubMed Web of Science ®Google Scholar
• Chen J Muntner P Hamm LL Insulin resistance and risk of chronic kidney disease in nondiabetic US adults J Am Soc Nephrol 2003 14 2 469 477 12538749
   PubMed Web of Science ®Google Scholar
• Nerpin E Risérus U Ingelsson E Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort Diabetes Care 2008 31 8 1550 1555 18509205
   PubMed Web of Science ®Google Scholar
• Li Y Xie D Qin X Metabolic syndrome, but not insulin resistance, is associated with an increased risk of renal function decline Clin Nutr Epub 4 16 2014
   Web of Science ®Google Scholar
• Aksentijević D Bhandari S Seymour AM Insulin resistance and altered glucose transporter 4 expression in experimental uremia Kidney Int 2009 75 7 711 718 19177156
   PubMed Web of Science ®Google Scholar
• Sun DF Chen Y Rabkin R Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia Kidney Int 2006 70 3 453 459 16871256
   PubMed Web of Science ®Google Scholar
• Ma KW Greene EL Raij L Cardiovascular risk factors in chronic renal failure and hemodialysis populations Am J Kidney Dis 1992 19 6 505 513 1534442
   PubMed Web of Science ®Google Scholar
• Feneberg R Sparber M Veldhuis JD Mehls O Ritz E Schaefer F Altered temporal organization of plasma insulin oscillations in chronic renal failure J Clin Endocrinol Metab 2002 87 5 1965 1973 11994326
   PubMed Web of Science ®Google Scholar
• Hager SR Insulin resistance of uremia Am J Kidney Dis 1989 14 4 272 276 2679057
   PubMed Web of Science ®Google Scholar
• DeFronzo RA Alvestrand A Smith D Hendler R Hendler E Wahren J Insulin resistance in uremia J Clin Invest 1981 67 2 563 568 7007440
   PubMed Web of Science ®Google Scholar
• Fliser D Pacini G Engelleiter R Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease Kidney Int 1998 53 5 1343 1347 9573550
   PubMed Web of Science ®Google Scholar
• Kato Y Hayashi M Ohno Y Suzawa T Sasaki T Saruta T Mild renal dysfunction is associated with insulin resistance in chronic glomerulonephritis Clin Nephrol 2000 54 5 366 373 11105797
   PubMed Web of Science ®Google Scholar
• Kobayashi S Maesato K Moriya H Ohtake T Ikeda T Insulin resistance in patients with chronic kidney disease Am J Kidney Dis 2005 45 2 275 280 15685504
   PubMed Web of Science ®Google Scholar
• Landau M Kurella-Tamura M Shlipak MG Health, Aging and Body Composition Study Correlates of insulin resistance in older individuals with and without kidney disease Nephrol Dial Transplant 2011 26 9 2814 2819 21248294
   PubMed Web of Science ®Google Scholar
• Cheng HT Huang JW Chiang CK Yen CJ Hung KY Wu KD Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly J Clin Endocrinol Metab 2012 97 4 1268 1276 22337909
   PubMed Web of Science ®Google Scholar
• Kobayashi S Maejima S Ikeda T Nagase M Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis Nephrol Dial Transplant 2000 15 1 65 70 10607769
   PubMed Web of Science ®Google Scholar
• Kovács T Vas T Kovesdy C Metabolic syndrome and other cardiovascular risk factors associated with the progression of IgA nephropathy Clin Kidney J 2012 0 1 7
   Google Scholar
• Saito T Mochizuki T Uchida K Tsuchiya K Nitta K Metabolic syndrome and risk of progression of chronic kidney disease: a single-center cohort study in Japan Heart Vessels 2013 28 3 323 329 22526382
   PubMed Web of Science ®Google Scholar
• Wang C Blough ER Arvapalli R Metabolic syndrome-induced tubulointerstitial injury: role of oxidative stress and preventive effects of acetaminophen Free Radic Biol Med 2013 65 1417 1426 24140865
   PubMed Web of Science ®Google Scholar
• Wisse BE The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity J Am Soc Nephrol 2004 15 11 2792 2800 15504932
   PubMed Web of Science ®Google Scholar
• Lee JE Choi SY Huh W Kim YG Kim DJ Oh HY Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults Am J Hypertens 2007 20 11 1189 1194 17954366
   PubMed Web of Science ®Google Scholar
• Wajchenberg BL Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome Endocr Rev 2000 21 6 697 738 11133069
   PubMed Web of Science ®Google Scholar
• Manrique C Lastra G Gardner M Sowers JR The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress Med Clin North Am 2009 93 3 569 582 19427492
   PubMed Web of Science ®Google Scholar
• Nashar K Nguyen JP Jesri A Morrow JD Egan BM Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome Am J Hypertens 2004 17 6 477 482 15177518
   PubMed Web of Science ®Google Scholar
• Taal MW Arterial stiffness in chronic kidney disease: an update Curr Opin Nephrol Hypertens 2014 23 2 169 173 24389732
   PubMed Web of Science ®Google Scholar
• Nitta K Possible link between metabolic syndrome and chronic kidney disease in the development of cardiovascular cisease Cardiol Res Pract 2011 2011 963517 20953380
   PubMedGoogle Scholar
• Wolf G Chen S Han DC Ziyadeh FN Leptin and renal disease Am J Kidney Dis 2002 39 1 1 11 11774095
   PubMed Web of Science ®Google Scholar
• Kirchheim H Ehmke H Persson P Sympathetic modulation of renal hemodynamics, renin release and sodium excretion Klin Wochenschr 1989 67 17 858 864 2681964
   PubMedGoogle Scholar
• Kon V Neural control of renal circulation Miner Electrolyte Metab 1989 15 1–2 33 43 2644521
   PubMedGoogle Scholar
• Wolf G Hamann A Han DC Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [see comments] Kidney Int 1999 56 3 860 872 10469355
   PubMed Web of Science ®Google Scholar
• Kim HJ Vaziri ND Norris K An WS Quiroz Y Rodriguez-Iturbe B High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease Clin Exp Nephrol 2010 14 6 536 547 20820841
   PubMed Web of Science ®Google Scholar
• Praga M Obesity – a neglected culprit in renal disease Nephrol Dial Transplant 2002 17 7 1157 1159 12105233
   PubMed Web of Science ®Google Scholar
• Steppan CM Bailey ST Bhat S The hormone resistin links obesity to diabetes Nature 2001 409 6818 307 312 11201732
   PubMed Web of Science ®Google Scholar
• Goldstein BJ Scalia R Adiponectin: a novel adipokine linking adipocytes and vascular function J Clin Endocrinol Metab 2004 89 6 2563 2568 15181024
   PubMed Web of Science ®Google Scholar
• Sharma K Ramachandrarao S Qiu G Adiponectin regulates albuminuria and podocyte function in mice J Clin Invest 2008 118 5 1645 1656 18431508
   PubMed Web of Science ®Google Scholar
• Becker B Kronenberg F Kielstein JT MMKD Study Group Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study J Am Soc Nephrol 2005 16 4 1091 1098 15743998
   PubMed Web of Science ®Google Scholar
• Zoccali C Mallamaci F Tripepi G Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease J Am Soc Nephrol 2002 13 1 134 141 11752030
   PubMed Web of Science ®Google Scholar
• Preble WE Obesity: observations on one thousand cases Boston Med Surg J 1923 188 617 621
   Google Scholar
• Hsu CY McCulloch CE Iribarren C Darbinian J Go AS Body mass index and risk for end-stage renal disease Ann Intern Med 2006 144 1 21 28 16389251
   PubMed Web of Science ®Google Scholar
• Chen S Chen Y Liu X Association of insulin resistance with chronic kidney disease in non-diabetic subjects with normal weight PLoS One 2013 8 9 e74058 24058515
   PubMed Web of Science ®Google Scholar
• Ryu S Chang Y Woo HY Changes in body weight predict CKD in healthy men J Am Soc Nephrol 2008 19 9 1798 1805 18495960
   PubMed Web of Science ®Google Scholar
• Praga M Hernández E Herrero JC Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy Kidney Int 2000 58 5 2111 2118 11044232
   PubMed Web of Science ®Google Scholar
• Kambham N Markowitz GS Valeri AM Lin J D’Agati VD Obesity-related glomerulopathy: an emerging epidemic Kidney Int 2001 59 4 1498 1509 11260414
   PubMed Web of Science ®Google Scholar
• Othman M Kawar B El Nahas AM Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study Nephron Clin Pract 2009 113 1 c16 c23 19590231
   PubMedGoogle Scholar
• Wang Y Chen X Song Y Caballero B Cheskin LJ Association between obesity and kidney disease: a systematic review and meta-analysis Kidney Int 2008 73 1 19 33 17928825
   PubMed Web of Science ®Google Scholar
• Munkhaugen J Lydersen S Widerøe TE Hallan S Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway Am J Kidney Dis 2009 54 4 638 646 19515474
   PubMed Web of Science ®Google Scholar
• Alberti KG Zimmet P Shaw J IDF Epidemiology Task Force Consensus Group The metabolic syndrome – a new worldwide definition Lancet 2005 366 9491 1059 1062 16182882
   PubMed Web of Science ®Google Scholar
• Ross R Freeman J Hudson R Janssen I Abdominal obesity, muscle composition, and insulin resistance in premenopausal women J Clin Endocrinol Metab 2002 87 11 5044 5051 12414870
   PubMed Web of Science ®Google Scholar
• Wagenknecht LE Langefeld CD Scherzinger AL Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study Diabetes 2003 52 10 2490 2496 14514631
   PubMed Web of Science ®Google Scholar
• Abate N Garg A Peshock RM Stray-Gundersen J Grundy SM Relationships of generalized and regional adiposity to insulin sensitivity in men J Clin Invest 1995 96 1 88 98 7615840
   PubMed Web of Science ®Google Scholar
• Goodpaster BH Thaete FL Simoneau JA Kelley DE Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat Diabetes 1997 46 10 1579 1585 9313753
   PubMed Web of Science ®Google Scholar
• Klag MJ Whelton PK Randall BL Blood pressure and end-stage renal disease in men N Engl J Med 1996 334 1 13 18 7494564
   PubMed Web of Science ®Google Scholar
• Jiang X Srinivasan SR Radhakrishnamurthy B Dalferes ERjr Bao W Berenson GS Microalbuminuria in young adults related to blood pressure in a biracial (black-white) population. The Bogalusa Heart Study Am J Hypertens 1994 7 9 Pt 1 794 800 7811437
   PubMed Web of Science ®Google Scholar
• Srinivasan SR Myers L Berenson GS Risk variables of insulin resistance syndrome in African-American and Caucasian young adults with microalbuminuria: the Bogalusa Heart Study Am J Hypertens 2000 13 12 1274 1279 11130771
   PubMed Web of Science ®Google Scholar
• Mänttäri M Tiula E Alikoski T Manninen V Effects of hypertension and dyslipidemia on the decline in renal function Hypertension 1995 26 4 670 675 7558229
   PubMed Web of Science ®Google Scholar
• Muntner P Coresh J Smith JC Eckfeldt J Klag MJ Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study Kidney Int 2000 58 1 293 301 10886574
   PubMed Web of Science ®Google Scholar
• Hunsicker LG Adler S Caggiula A Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study Kidney Int 1997 51 16 1908 1919 9186882
   PubMed Web of Science ®Google Scholar
• Bose S Bomback AS Mehta NN KEEP investigators Dysglycemia but not lipids is associated with abnormal urinary albumin excretion in diabetic kidney disease: a report from the Kidney Early Evaluation Program (KEEP) BMC Nephrol 2012 13 104 22958709
   PubMed Web of Science ®Google Scholar
• Agrawal V Shah A Rice C Franklin BA McCullough PA Impact of treating the metabolic syndrome on chronic kidney disease Nat Rev Nephrol 2009 5 9 520 528 19636332
   PubMed Web of Science ®Google Scholar
• Bestermann W Houston MC Basile J Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome Am J Med Sci 2005 329 6 292 305 15958871
   PubMed Web of Science ®Google Scholar
• Gaede P Vedel P Parving HH Pedersen O Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study Lancet 1999 353 9153 617 622 10030326
   PubMed Web of Science ®Google Scholar
• Hallan S de Mutsert R Carlsen S Dekker FW Aasarød K Holmen J Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis 2006 47 3 396 405 16490617
   PubMed Web of Science ®Google Scholar
• Finkelstein J Joshi A Hise MK Association of physical activity and renal function in subjects with and without metabolic syndrome: a review of the Third National Health and Nutrition Examination Survey (NHANES III) Am J Kidney Dis 2006 48 3 372 382 16931210
   PubMed Web of Science ®Google Scholar
• Ibrahim HN Weber ML Weight loss: a neglected intervention in the management of chronic kidney disease Curr Opin Nephrol Hypertens 2010 19 6 534 538 20827193
   PubMed Web of Science ®Google Scholar
• Chagnac A Weinstein T Korzets A Ramadan E Hirsch J Gafter U Glomerular hemodynamics in severe obesity Am J Physiol Renal Physiol 2000 278 5 F817 F822 10807594
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K Block G Humphreys MH Kopple JD Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients Kidney Int 2003 63 3 793 808 12631061
   PubMed Web of Science ®Google Scholar
• Lindholm A Bixo M Björn I Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial Fertil Steril 2008 89 5 1221 1228 17603048
   PubMed Web of Science ®Google Scholar
• Filippatos TD Kiortsis DN Liberopoulos EN Georgoula M Mikhailidis DP Elisaf MS Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study Curr Med Res Opin 2005 21 12 1997 2006 16368051
   PubMed Web of Science ®Google Scholar
• Kurata A Nishizawa H Kihara S Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation Kidney Int 2006 70 10 1717 1724 16985520
   PubMed Web of Science ®Google Scholar
• Fried LF Orchard TJ Kasiske BL Effect of lipid reduction on the progression of renal disease: a meta-analysis Kidney Int 2001 59 1 260 269 11135079
   PubMed Web of Science ®Google Scholar
• Tonelli M Wanner C Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guideline Ann Intern Med 2014 160 3 182 24323134
   PubMed Web of Science ®Google Scholar
• Kitiyakara C Yamwong S Cheepudomwit S The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort Kidney Int 2007 71 7 693 700 17290290
   PubMed Web of Science ®Google Scholar
• Bakker SJ Gansevoort RT de Zeeuw D Metabolic syndrome: a fata morgana? Nephrol Dial Transplant 2007 22 1 15 20 17050636
   PubMed Web of Science ®Google Scholar
• Lea JP Greene EL Nicholas SB Agodoa L Norris KC Cardiorenal metabolic syndrome in the African diaspora: rationale for including chronic kidney disease in the metabolic syndrome definition Ethn Dis 2009 19 2 Suppl 2 S2 S11 19537345
   PubMed Web of Science ®Google Scholar
• Gluba A Mikhailidis DP Lip GY Hannam S Rysz J Banach M Metabolic syndrome and renal disease Int J Cardiol 2013 164 2 141 150 22305775
   PubMed Web of Science ®Google Scholar
• Lea J Cheek D Thornley-Brown D AASK Study Investigators Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans Am J Kidney Dis 2008 51 5 732 740 18436083
   PubMed Web of Science ®Google Scholar